Qiagen NV reported $884.85M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
argenx SE 35.57M 32.76M Jun/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Moderna USD 32M 3M Jun/2025
Organon & Co USD 8.9B 36M Jun/2025
Qiagen NV USD 884.85M 467.8M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Tectonic Therapeutic USD 186K 201K Jun/2025
Viatris USD 12.79B 1.39B Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025